During the past decade, CHU Yalgado Ouedraogo conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU Yalgado Ouedraogo" are "HIV Infection" (1 trials) and "HIV-2 Infection" (1 trials). Many other conditions were trialed in "CHU Yalgado Ouedraogo" in a lesser frequency.

Most popular intervention types in "CHU Yalgado Ouedraogo" are "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Lopinavir/ritonavir" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Raltegravir" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Zidovudine" (1 trials) and "adherence reinforcement" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Yalgado Ouedraogo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU Yalgado Ouedraogo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHU Yalgado Ouedraogo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Yalgado Ouedraogo, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".